Skip to main content

Table 4 Case attributes by type of substances (N = 664)

From: Evaluation of performance-enhancing drugs seized by Israeli enforcement agencies 2012–2017: implications for policy and regulatory change

TypeAASa (N = 539)Others Substancesb (N = 125)dfχ 2Sig
N (%)N (%)
Gender
Male489 (90.7)115 (92)1.201.065
Female50 (9.3)10 (8.0)   
Year
201222 (4.1)7 (5.6)519.701.001
201359 (11,0)23 (18.4)   
2014158 (29.3)24 (19.2)   
201587 (16.1)21 (16.8)   
2016112 (20.8)39 (31.2)   
2017101 (18.7)11 (8.8)   
Place of Seizure
Land and Air ports of entry118 (21.9)10 (8.0)313.594.004
Mail and Packages processing centers207 (38.4)51 (40.8)   
Private premises181 (33.6)55 (44.0)   
Public or commercial properties33 (6.1)9 (7.2)   
  1. aAnabolic Androgenic Steroids
  2. bWADA prohibited substances from the following categories: Adrenergic and sympathomimetic agent; Diuretics, Sodium and potassium supplements; Hormones, Growth hormones, and hormone releasing agent; Post-cycle and adverse effects treatment agents and site-enhancing oils